To validate the role of the MYC/CTR1 axis in HCC, we assessed the expression of MYC and CTR1 in normal, NAFLD-cirrhotic and -HCC tissues by using immunohistochemical staining (Figure 4C). This evidence concerns the gene MYC and hepatocellular carcinoma.